Evidence map›Paper›PMID 32194325›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2020

Antiproliferative and antimigratory effects of 3-(4-substituted benzyl)-5- isopropyl-5-phenylhydantoin derivatives in human breast cancer cells.

Ana Obradović, Miloš Matić, Branka Ognjanović, Predrag Đurđević, Emilija Marinković, Gordana Ušćumlić, Bojan Božić, Biljana Božić Nedeljković

Abstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana ObradovićDepartment of Biology and Ecology, Faculty of Science, University of Kragujevac, Kragujevac, Serbia.
Miloš MatićDepartment of Biology and Ecology, Faculty of Science, University of Kragujevac, Kragujevac, Serbia.
Branka OgnjanovićDepartment of Biology and Ecology, Faculty of Science, University of Kragujevac, Kragujevac, Serbia.
Predrag ĐurđevićDepartment of Internal Medicine, Clinic for Hematology Clinical Center Kragujevac, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Emilija MarinkovićDepartment of Research and Development, Institute of Virology, Vaccines and Sera - TORLAK, Belgrade, Serbia.
Gordana UšćumlićDepartment of Organic Chemistry, Faculty of Technology and Metallurgy, University of Belgrade, Belgrade, Serbia.
Bojan BožićInstitute of Physiology and Biochemistry "Ivan Đaja", Faculty of Biology, University of Belgrade, Belgrade, Serbia.
Biljana Božić NedeljkovićInstitute of Physiology and Biochemistry "Ivan Đaja", Faculty of Biology, University of Belgrade, Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, a series of synthesized 3-(4-substituted benzyl)-5-isopropyl-5-phenylhydantoin derivatives as a potential antiproliferative and antimigratory agents were investigated. The possible antitumor mechanisms of investigated hydantoin derivatives were examined on human breast cancer cell line MDA-MB-231. The cells were treated with different concentrations of compounds (from 0.01 µM to 100 µM) during 24 h and 72 h. The proliferation index, nitric oxide production, apoptosis rate, and migration capacity were measured. The cell invasion potential was examined by measuring the level of MMP-9 and COX-2 gene expression. All tested compounds expressed antiproliferative activity and induced dose- and time-dependent increase in the level of nitrites. The investigated molecules significantly decreased cell survival rate, migration capacity and the expression levels of genes included in the process of tumor invasion. Obtained data suggest that the tested hydantoin derivatives express considerable antitumor activity by reducing cell division rate, elevating apoptosis level, and inhibiting the motility and invasiveness of breast cancer cells. The results obtained in this study indicate that investigated compounds express potential as a novel chemotherapeutic agents against breast cancer growth and progression.

Indexed as

ApoptosisBreast cancer cell line MDA-MB-231Cell motilityHydantoin derivativesNitric oxideProliferation

Identifiers

PMID32194325
PMCPMC7078530

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.